2018
DOI: 10.1001/jamaneurol.2018.1578
|View full text |Cite
|
Sign up to set email alerts
|

Association of Retinal Nerve Fiber Layer Thinning With Current and Future Cognitive Decline

Abstract: Identifing potential screening tests for future cognitive decline is a priority for developing treatments for and the prevention of dementia. OBJECTIVE To examine the potential of retinal nerve fiber layer (RNFL) thickness measurement in identifying those at greater risk of cognitive decline in a large community cohort of healthy people. DESIGN, SETTING, AND PARTICIPANTS UK Biobank is a prospective, multicenter, community-based study of UK residents aged 40 to 69 years at enrollment who underwent baseline reti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
149
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 148 publications
(154 citation statements)
references
References 39 publications
(87 reference statements)
5
149
0
Order By: Relevance
“…In the wider population, RNFL thinning is linked with higher rates of cognitive decline, 7 and another study found that GC-IPL thinning (but not RNFL) is linked with prevalent dementia. 8 Our finding of a link between retinal thinning and risk of dementia may not be wholly specific to Parkinson dementia and may also apply to other types of dementia.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the wider population, RNFL thinning is linked with higher rates of cognitive decline, 7 and another study found that GC-IPL thinning (but not RNFL) is linked with prevalent dementia. 8 Our finding of a link between retinal thinning and risk of dementia may not be wholly specific to Parkinson dementia and may also apply to other types of dementia.…”
Section: Discussionmentioning
confidence: 99%
“…Retinal structure can be imaged noninvasively using optical coherence tomography (OCT) 4 and shows thinning in Alzheimer disease 5 and as a population screen for dementia. [6][7][8] Retinal structural changes are seen in PD, but early studies of retinal nerve fiber layer (RNFL) thinning in PD were not replicated. 9 The location of dopaminergic amacrine cells in the inner plexiform layer (IPL) 10 in nonhuman studies, and postmortem findings of phosphorylated alpha-synuclein in the IPL, suggest that deeper layers are more likely to be affected in PD.…”
mentioning
confidence: 99%
“…Recent studies have demonstrated significant RNFL thinning in collision sport athletes and Olympic boxers, however, the former study by Leong et al failed to demonstrate statistically significant RNFL thinning in subgroup analysis of American Football players. Furthermore, studies have reported that RNFL thinning in individuals without a neurodegenerative disease is associated with reduced visual acuity and worse cognitive function . RNFL thinning has also been shown to predict a greater likelihood of future cognitive decline and dementia …”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, studies have reported that RNFL thinning in individuals without a neurodegenerative disease is associated with reduced visual acuity 26 and worse cognitive function. 28 RNFL thinning has also been shown to predict a greater likelihood of future cognitive decline 28 and dementia. 29 Two recent studies have demonstrated a correlation between RNFL thinning and brain atrophy as assessed on MRI.…”
Section: Introductionmentioning
confidence: 99%
“…The retina, the neural layer of the eye, is a developmental extension of the brain and is the only part of the CNS that can be optically imaged in vivo . The retina manifests features of CNS diseases, and methods to detect retinal biomarkers of Alzheimer's disease are in various stages of development (Hinton et al, ; Jentsch et al, ; Koronyo et al, ; van Wijngaarden et al, ; Ko et al, ). Several imaging approaches have been postulated to measure NADH and FAD autofluorescence in vivo (Elner et al, ; Jentsch et al, ).…”
Section: Mitochondrial Function As a Biomarker In Alzheimer's Diseasementioning
confidence: 99%